Skip to content

Clinical trials

Lymphoma, Follicular trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Country / region: Germany Clear all

140 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20031
20043
20054
20065
20072
20082
20095
20108
20117
20123
20139
20144
20154
20164
20176
20189
20194
20205
20216
202213
20237
20248
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72
Recruiting20
Terminated20
Active, not recruiting18
Unknown status6
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Regeneron Pharmaceuticals9
European Organisation for Research and Treatment of Cancer - EORTC6
Pfizer6
Celgene5
Fred Hutchinson Cancer Center5
German High-Grade Non-Hodgkin's Lymphoma Study Group5
Hoffmann-La Roche5
Janssen Research & Development, LLC4
AstraZeneca3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular140
Lymphoma, Non-Hodgkin46
Lymphoma, Large B-Cell, Diffuse39
Lymphoma, B-Cell, Marginal Zone35
Lymphoma, Mantle-Cell34
Leukemia, Lymphocytic, Chronic, B-Cell29
Lymphoma21
Waldenstrom Macroglobulinemia20
Burkitt Lymphoma17
Recurrence17

Trials

Showing 51 to 75 of 140. Each trial links to its page on Pharma Observatory.

40 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.